Necrolytic Migratory Erythema.
Liu JW, Qian YT, Ma DL.
JAMA Dermatol. 2019 Oct 1;155(10):1180. doi: 10.1001/jamadermatol.2019.1658.
Necrolytic Migratory Erythema.
Foss MG, Hashmi MF, Ferrer-Bruker SJ.
2023 Jul 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Necrolytic migratory erythema.
Lee HJ, Jang YH.
CMAJ. 2019 Mar 11;191(10):E286. doi: 10.1503/cmaj.180913.
Glucagonoma-related necrolytic migratory erythema.
Bosch-Amate X, Riera-Monroig J, Iranzo Fernández P.
Med Clin (Barc). 2020 Nov 13;155(9):418-419. doi: 10.1016/j.medcli.2019.06.027. Epub 2019 Sep 9.
Necrolytic migratory erythema.
Kovács RK, Korom I, Dobozy A, Farkas G, Ormos J, Kemény L.
J Cutan Pathol. 2006 Mar;33(3):242-5. doi: 10.1111/j.0303-6987.2006.00408.x.
Necrolytic Migratory Erythema with Neuroendocrine Tumors.
Sun J, Song X.
QJM. 2025 Jul 30:hcaf172. doi: 10.1093/qjmed/hcaf172. Online ahead of print.
Necrolytic migratory erythema: a fortuitous diagnosis.
Kanagarajan A, Babu D, Chandrasekaran S.
BMJ Case Rep. 2024 Nov 27;17(11):e260893. doi: 10.1136/bcr-2024-260893.
Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma.
Li W, Yang X, Deng Y, Jiang Y, Xu G, Li E, Wu Y, Ren J, Ma Z, Dong S, Han L, Ma Q, Wu Z, Wang Z.
Sci Rep. 2022 May 31;12(1):9053. doi: 10.1038/s41598-022-12882-2.
Necrolytic migratory erythema as a cutaneous manifestation of a pancreatic neuroendocrine tumor.
de Carlos J, Saldaña C, Bonaut B, Cerezo C.
Dig Liver Dis. 2022 Nov;54(11):1583-1585. doi: 10.1016/j.dld.2022.05.017. Epub 2022 Jun 18.
Zinc and Skin Disorders.
Ogawa Y, Kinoshita M, Shimada S, Kawamura T.
Nutrients. 2018 Feb 11;10(2):199. doi: 10.3390/nu10020199.
